Dr. Jorge J. Castillo, MD
- Medicare services, 2024
- 889
- Medicare patients, 2024
- 457
- Part D claims, 2024
- 340
- Publications
- 265
- Clinical trials
- 10
- Practice address
- 450 Brookline Avenue, Boston, MA 02115
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Castillo's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jorge J. Castillo is a hematologist and oncologist in Boston, Massachusetts
Dr. Castillo practices at Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute.
Dr. Castillo's NPI, 1689891129, was assigned on April 19, 2007. Dr. Castillo graduated from Autonomous Metropolitan University Xochimilco in 1996. Dr. Castillo holds Massachusetts license 257257.
- NPI
- 1689891129NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880758796
- NPI enumeration date
- April 19, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jorge J. Castillo practices at Dana-Farber Cancer Institute in Boston, Massachusetts
Dr. Castillo's primary practice is Dana-Farber Cancer Institute, at 450 Brookline Avenue, Boston, MA 02115.
- Dana-Farber Cancer Institute450 Brookline Avenue, Boston, MA 02115
Source: Dmand AI Affiliation Data
Dr. Jorge J. Castillo is affiliated with 5 sites of care and 1 medical group
Dr. Castillo's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dr. Castillo is also affiliated with Massachusetts General Hospital. The medical group on file is Binney Medical Group. Dmand AI also links Dr. Castillo to 3 more hospitals, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jorge J. Castillo's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Castillo practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dana-Farber Cancer Institute | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dana-Farber Cancer Institute and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jorge J. Castillo is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Castillo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Castillo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Castillo's licenses on file in 4 states: Massachusetts, Florida, New Hampshire and Rhode Island.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
- Florida license
- New Hampshire license
- Hematology (internal medicine), Rhode Island
Clinical focus
Dmand AI lists chronic anemia, chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Castillo treats.
Hematologists and oncologists near Dr. Castillo
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jorge J. Castillo billed Medicare for 889 services in 2024
CMS data shows 889 Medicare services from Dr. Castillo across 7 procedure codes in 2024, for 457 Medicare patients. Medicare paid $78,933 for them.
Dr. Castillo's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 7202024: 84618%
- Other services
- 2023: 422024: 432%
Where Dr. Castillo's Medicare services took place, 2024
- In an office12514%
- In a facility76486%
Dr. Castillo compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Castillo
- Massachusetts median
- Medicare services
- 889vs 49580% above
- Medicare patients
- 457vs 2002.3 times
- Part D claims
- 324vs 1512.1 times
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Castillo's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Castillo?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Castillo and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jorge J. Castillo treated 457 Medicare patients in 2024, average age 75
CMS counts 457 Medicare patients who saw Dr. Castillo in 2024. The largest group is 65 to 74, with 228 patients. 58% of them have high cholesterol, and 53% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Castillo's median patient age at 74, with 42% women.
Dr. Castillo's Medicare patients by age, 2024
Dr. Castillo's Medicare patients by sex, 2024
- Women19743%
- Men26057%
Chronic conditions among Dr. Castillo's Medicare patients, 2024
- High cholesterol58%
- High blood pressure53%
- Arthritis45%
- Anxiety23%
- Atrial fibrillation22%
- Ischemic heart disease22%
- Osteoporosis21%
- Mood disorders20%
Share of Medicare patients with each condition. A patient can have several.
Dr. Castillo's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women42%
- Men56%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jorge J. Castillo wrote 340 Medicare Part D claims in 2024
In 2024, Dr. Castillo wrote 340 Medicare Part D claims for 75 patients. 4% of them were for generic drugs. CMS names the drug for 324 of them, across 3 drugs with 11 or more claims each, at $4,060,727 in total drug cost. In 2023, CMS named 472 claims across 3 drugs.
Dr. Castillo's Part D claims by kind of drug, 2024
- Generic15 claims4%
- Brand-name325 claims96%
Dr. Castillo's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4722024: 32431%
Drugs named by CMS: 3 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Jorge J. Castillo scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Castillo for performance year 2024, reported as part of a group. Dr. Castillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Castillo as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Castillo's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jorge J. Castillo has 265 publications on record
Dmand AI links 265 papers to Dr. Castillo, published from 2009 to 2025. 2021 was the busiest year, with 16. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse and Waldenstrom Macroglobulinemia. Dr. Castillo has published most often in Am J Hematol. Dr. Castillo's most frequent co-authors are Shayna R. Sarosiek, MD, Roberto N. Miranda, MD and Andrew R. Branagan, MD.
Dr. Castillo's papers by year, 2016 to 2025
Topics Dr. Castillo writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Lymphoma, Large B-Cell, Diffuse
- Waldenstrom Macroglobulinemia
- Antineoplastic Agents
- Multiple Myeloma
- Rituximab
- Cyclophosphamide
- Doxorubicin
Dr. Castillo's most frequent co-authors
- Shayna R. Sarosiek, MD22 shared papers
- Roberto N. Miranda, MD18 shared papers
- Andrew R. Branagan, MD10 shared papers
Recent publications by Dr. Castillo
See who Dr. Castillo researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Castillo works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jorge J. Castillo has worked on 10 clinical trials
Dmand AI links Dr. Castillo to 10 clinical trials, 8 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Waldenstrom Macroglobulinemia, Blood Protein Disorders and Lymphoma, B-Cell, Marginal Zone. Dana-Farber Cancer Institute sponsors the most, 6. Open Payments lists research payments to Dr. Castillo that name 1 trial.
Clinical trials with Dr. Castillo by phase
- 1Phase 1: 1 trial
- 8Phase 2: 8 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Castillo's trials
- Waldenstrom Macroglobulinemia
- Blood Protein Disorders
- Lymphoma, B-Cell, Marginal Zone
- Neuritis
Investigators on the most trials with Dr. Castillo
- Andrew R. Branagan, MD2 shared trials
- Ranjana Advani, MD1 shared trial
- John Nathan Allan, MD1 shared trial
Recent clinical trials with Dr. Castillo
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy (opens in a new tab)
Ibrutinib + Venetoclax in Untreated WM (opens in a new tab)
Dasatinib In Waldenström Macroglobulinemia (opens in a new tab)
A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Jorge J. Castillo received $213,693 in industry payments from 2016 to 2025
CMS Open Payments shows 226 general payments to Dr. Castillo from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. BeiGene, Ltd. paid the most, $72,417. It also lists 3 research payments totaling $770,662 from 2019 to 2024, naming 1 clinical trial.
General payments to Dr. Castillo by program year, 2016 to 2025
General payments to Dr. Castillo by kind, 2016 to 2025
- Consulting fees$173,73581%
- Travel and lodging$21,69010%
- Speaker and faculty fees$11,8506%
- Food and beverage$6,4033%
- Education$150%
Companies that paid Dr. Castillo the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jorge J. Castillo has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Castillo, most recently Innovation in 2022. Dr. Castillo serves on IWMF Scientific Advisory Committee and NCCN (Myeloma Waldenstrom and Amyloidosis).
Awards and honors for Dr. Castillo
- 2022
- Innovation
- Robert A. Kyle Award
Dr. Castillo's committees and leadership roles
- IWMF Scientific Advisory CommitteeMember
- 2020 to present
- NCCN (Myeloma Waldenstrom and Amyloidosis)Member
- 2016 to present
Source: Dmand AI Professional Profile Data
Dr. Jorge J. Castillo graduated from Autonomous Metropolitan University Xochimilco
Dr. Castillo graduated from Autonomous Metropolitan University Xochimilco in 1996. Dr. Castillo is a member of ASCO, ASH, European Haematology Association and International Myeloma Society.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Jorge J. Castillo accepts plans from 13 insurance carriers
Dr. Castillo is in network with 13 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- Humana
- Molina
- +5 more carriersWith a free account
Plan types Dr. Castillo accepts, by number of carriers
- Medicare10
- PPO9
- HMO5
- Medicaid3
- POS3
- EPO2
Source: Dmand AI Insurance Network Data
Sources for Dr. Jorge J. Castillo's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jorge J. Castillo
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jorge J. Castillo's NPI number?
Dr. Jorge J. Castillo's NPI number is 1689891129. It was assigned on April 19, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Jorge J. Castillo?
Dr. Jorge J. Castillo is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jorge J. Castillo practice?
Dr. Castillo practices at 450 Brookline Avenue, Boston, MA 02115. Dr. Castillo's primary practice is Dana-Farber Cancer Institute in Boston, Massachusetts, part of Dana-Farber Cancer Institute. Dmand AI also links Dr. Castillo to 3 hospitals.
What is Dr. Jorge J. Castillo's medical license number?
Dr. Castillo holds Massachusetts license 257257, one of the licenses on file in 4 states.
Which states has Dr. Jorge J. Castillo been licensed in?
Dmand AI has state licenses on file for Dr. Castillo in Massachusetts (2013 to 2026), Florida (since 2022), New Hampshire (2023 to 2027) and Rhode Island (2005 to 2014).
Which hospitals is Dr. Jorge J. Castillo affiliated with?
Dr. Castillo practices at Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Castillo is also affiliated with Massachusetts General Hospital. Dmand AI links Dr. Castillo to 3 more hospitals.
What medical group is Dr. Jorge J. Castillo part of?
Dr. Castillo is linked to Binney Medical Group.
Does Dr. Jorge J. Castillo accept Medicare?
Yes. CMS data shows Dr. Castillo billed Medicare for 889 services in 2024, and Dr. Castillo accepts Medicare assignment.
Does Dr. Jorge J. Castillo offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Castillo as offering telehealth services.
What is Dr. Jorge J. Castillo's MIPS score?
Dr. Castillo's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Jorge J. Castillo see?
CMS counts 457 Medicare patients who saw Dr. Castillo in 2024, with an average age of 75.
Is Dr. Jorge J. Castillo board certified?
Yes. Dr. Castillo is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Jorge J. Castillo bill to Medicare?
In 2024, Dr. Castillo's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99232).
Where did Dr. Jorge J. Castillo go to medical school?
Dr. Castillo graduated from Autonomous Metropolitan University Xochimilco in 1996.
What drugs does Dr. Jorge J. Castillo prescribe most?
In 2024 Medicare Part D data, Dr. Castillo's most prescribed drugs by claims were Brukinsa, Imbruvica and Venclexta.
Has Dr. Jorge J. Castillo received payments from drug or device companies?
CMS Open Payments shows $213,693 in general payments to Dr. Castillo from 20 companies from 2016 to 2025. The largest total came from BeiGene, Ltd.
How long has Dr. Jorge J. Castillo been practicing?
Dr. Castillo graduated from medical school in 1996, 30 years ago.
Does Dr. Jorge J. Castillo do research?
Dmand AI links 265 publications to Dr. Castillo, published from 2009 to 2025. Dr. Castillo has worked on 10 clinical trials.
Who does Dr. Jorge J. Castillo publish with?
Dr. Castillo's most frequent co-authors are Shayna R. Sarosiek, MD (22 shared papers), Roberto N. Miranda, MD (18 shared papers) and Andrew R. Branagan, MD (10 shared papers).
What insurance does Dr. Jorge J. Castillo accept?
Dr. Castillo is in network with 13 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card